ATE346159T1 - Enzymatische spaltung von selektiven modulatoren des östrogenrezeptors - Google Patents

Enzymatische spaltung von selektiven modulatoren des östrogenrezeptors

Info

Publication number
ATE346159T1
ATE346159T1 AT01303554T AT01303554T ATE346159T1 AT E346159 T1 ATE346159 T1 AT E346159T1 AT 01303554 T AT01303554 T AT 01303554T AT 01303554 T AT01303554 T AT 01303554T AT E346159 T1 ATE346159 T1 AT E346159T1
Authority
AT
Austria
Prior art keywords
estrogen receptor
enzymatic cleavage
selective modulators
modulators
selective
Prior art date
Application number
AT01303554T
Other languages
English (en)
Inventor
Kevin Kun-Chin Liu
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE346159T1 publication Critical patent/ATE346159T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/165—Heterorings having nitrogen atoms as the only ring heteroatoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01013—Sterol esterase (3.1.1.13)
AT01303554T 2000-05-08 2001-04-19 Enzymatische spaltung von selektiven modulatoren des östrogenrezeptors ATE346159T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20241800P 2000-05-08 2000-05-08

Publications (1)

Publication Number Publication Date
ATE346159T1 true ATE346159T1 (de) 2006-12-15

Family

ID=22749787

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01303554T ATE346159T1 (de) 2000-05-08 2001-04-19 Enzymatische spaltung von selektiven modulatoren des östrogenrezeptors

Country Status (24)

Country Link
US (3) US6828134B2 (de)
EP (1) EP1156120B1 (de)
JP (1) JP2002000293A (de)
KR (1) KR100488385B1 (de)
CN (1) CN1322842A (de)
AR (1) AR031844A1 (de)
AT (1) ATE346159T1 (de)
AU (1) AU782597B2 (de)
BR (1) BR0101802A (de)
CA (1) CA2346426C (de)
CZ (1) CZ20011576A3 (de)
DE (1) DE60124616T2 (de)
ES (1) ES2274854T3 (de)
HK (1) HK1040264A1 (de)
HU (1) HUP0101874A3 (de)
ID (1) ID30106A (de)
IL (2) IL168341A (de)
MX (1) MXPA01004626A (de)
PL (1) PL347407A1 (de)
RU (1) RU2213778C2 (de)
SG (1) SG100688A1 (de)
TW (1) TWI237059B (de)
YU (1) YU31101A (de)
ZA (1) ZA200103666B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8853423B2 (en) 2010-06-17 2014-10-07 Seragon Pharmaceuticals, Inc. Indane estrogen receptor modulators and uses thereof
CN109750013B (zh) * 2019-03-27 2023-01-13 云南师范大学 一种脂肪酶突变体及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814282A (en) * 1984-05-03 1989-03-21 Abbott Laboratories Centrifuge for two-dimensional centrifugation
DE3638762A1 (de) * 1986-11-13 1988-05-26 Schering Ag Racematspaltung von 7(alpha)-acyloxy-6ss-hydroxy-methyl-2-oxabicyclo (3.3.0)octan-3-onen durch stereospezifische enzymatische acylat-hydrolyse
US5248609A (en) 1986-11-13 1993-09-28 Schering Aktiengesellschaft Racemic separation of 7α-acyloxy-6β-hydroxymethyl-2-oxabicyclo[3.]-octan-3-ones by stereospecific enzymatic acylate hydrolysis
DK171349B1 (da) 1986-11-14 1996-09-16 Hoffmann La Roche Tetrahydronaphthalenderivater, fremgangsmåde til fremstilling deraf, lægemidler indeholdende forbindelserne samt anvendelse af forbindelserne til fremstilling af lægemidler
US5106750A (en) * 1988-08-30 1992-04-21 G. D. Searle & Co. Enantio- and regioselective synthesis of organic compounds using enol esters as irreversible transacylation reagents
TW383306B (en) * 1992-12-22 2000-03-01 Lilly Co Eli New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol
FR2724184B1 (fr) * 1994-09-05 1997-01-03 Rhone Poulenc Chimie Procede de resolution d'un melange d'alcools stereoisomeres
US5589482A (en) * 1994-12-14 1996-12-31 Pfizer Inc. Benzo-thiophene estrogen agonists to treat prostatic hyperplasia
US5552412A (en) * 1995-01-09 1996-09-03 Pfizer Inc 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
UA51676C2 (uk) 1995-11-02 2002-12-16 Пфайзер Інк. (-)цис-6(s)-феніл-5(r)[4-(2-піролідин-1-ілетокси)феніл]-5,6,7,8-тетрагідронафталін-2-ол d-тартрат, спосіб його одержання, спосіб лікування захворювань, що піддаються лікуванню агоністами естрогену, та фармацевтична композиція
IL120266A (en) * 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
ZA985217B (en) * 1997-06-17 1999-01-07 Schering Corp Enzymatic kinetic resolution of an intermediate useful for preparing substituted tricyclics
PA8475901A1 (es) 1998-06-16 2000-05-24 Pfizer Prod Inc Terapia de combinacion para la fragilidad musculoesqueletica
ID23459A (id) 1998-08-28 2000-04-27 Pfizer Prod Inc Biotransformasi mikroba
US6180375B1 (en) 1999-08-27 2001-01-30 Pfizer Inc. Microbial biotransformation

Also Published As

Publication number Publication date
CN1322842A (zh) 2001-11-21
EP1156120A3 (de) 2004-02-18
CA2346426A1 (en) 2001-11-08
BR0101802A (pt) 2001-12-18
CA2346426C (en) 2006-08-01
PL347407A1 (en) 2001-11-19
US7351567B2 (en) 2008-04-01
HU0101874D0 (en) 2001-07-30
US6828134B2 (en) 2004-12-07
US20070249025A1 (en) 2007-10-25
HK1040264A1 (zh) 2002-05-31
SG100688A1 (en) 2003-12-26
AU782597B2 (en) 2005-08-11
JP2002000293A (ja) 2002-01-08
AR031844A1 (es) 2003-10-08
RU2213778C2 (ru) 2003-10-10
CZ20011576A3 (cs) 2002-02-13
ID30106A (id) 2001-11-08
IL142881A0 (en) 2002-03-10
HUP0101874A2 (hu) 2002-03-28
DE60124616T2 (de) 2007-09-13
US20020049219A1 (en) 2002-04-25
YU31101A (sh) 2005-07-19
EP1156120B1 (de) 2006-11-22
DE60124616D1 (de) 2007-01-04
AU4375801A (en) 2001-11-15
IL142881A (en) 2006-08-01
HUP0101874A3 (en) 2003-06-30
KR100488385B1 (ko) 2005-05-11
EP1156120A2 (de) 2001-11-21
KR20010102942A (ko) 2001-11-17
US20040176415A1 (en) 2004-09-09
TWI237059B (en) 2005-08-01
IL168341A (en) 2006-08-01
MXPA01004626A (es) 2004-09-10
ES2274854T3 (es) 2007-06-01
ZA200103666B (en) 2002-11-07

Similar Documents

Publication Publication Date Title
DK1140085T3 (da) Azabicycloalkan som CCR5-modulatorer
NO20015272L (no) Glukokortikoid reseptor modulatorer
LTC1284974I2 (lt) Triazoliltropano dariniai kaip CCR5 moduliatoriai
DE60110391D1 (de) Adenosin-rezeptor modulatoren
ATE418046T1 (de) Allzweckfeuerzeug
MX225999B (es) Polimorfo antifungico cristalino.
PT1100326E (pt) Microcapsulas de libertacao activada por bases
AU7922201A (en) Multiplexed enzymatic assays
DE60141214D1 (de) Enzymelektrode
ATE389148T1 (de) Allzweckfeuerzeug
ATE269253T1 (de) Teilbare mehrfachpackung
ATE346159T1 (de) Enzymatische spaltung von selektiven modulatoren des östrogenrezeptors
DE59903701D1 (de) Mehrfachpackung
NO20015453D0 (no) Enkeltsidebåndblander
KR970064395U (ko) 화장실용 다기능 음향기
EE9900224A (et) Arvete/konto väljavõtete saatmise meetod
DE29815262U1 (de) Rütteldrucklanze
FI20001808A (fi) Uusi entsyymi
NO980285L (no) Forgrenet muffe
ES1047796Y (es) Cizalla cortadora de ladrillos.
ES1046588Y (es) Expositor mondular de mamparas.
UA3465S (uk) Монограма
SE9801030D0 (sv) New enzymes
SE9900466D0 (sv) New assay
ES1045877Y (es) Disposicion de fieltros autoadhesivos.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties